Zobrazeno 1 - 10
of 798
pro vyhledávání: '"F. Fyhrquist"'
Publikováno v:
Bulletin des Sociétés Chimiques Belges. 89:729-735
Plasma renin activity (PRA) was measured by radioimmunoassay of angiotensin I generated during 1 hour incubation at the pH-optimum. Angiotensin I was then assayed directly in the plasma or after extraction on a Dowex resin. A significant (p < 0.001)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f690eb6273cb63e9b6046ac7be79a6f4
https://doi.org/10.1002/bscb.19800890905
https://doi.org/10.1002/bscb.19800890905
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 289:H2000-H2004
Nicotine, a component of cigarette smoke, has been implicated in the pathogenesis of cardiovascular disease. We examined whether nicotine regulates angiotensin-converting enzyme (ACE), an enzyme that plays an important role in the pathophysiology of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d9b28ea89c0d103ee0d0669385d5ba
https://doi.org/10.1152/ajpheart.01238.2004
https://doi.org/10.1152/ajpheart.01238.2004
Autor:
Gareth Beevers, Richard B. Devereux, Ulf de Faire, Sverre E. Kjeldsen, Darcy A. Hille, Giovanni de Simone, Lars H Lindholm, Hans Ibsen, Markku S. Nieminen, Vittorio Palmieri, Kristian Wachtell, Ole Lederballe-Pedersen, Björn Dahlöf, Stevo Julius, Suzanne Oparil, F Fyhrquist, Per Omvik
Publikováno v:
Circulation. 111:1924-1931
Background— Obesity may independently increase the risk of adverse events in hypertension with target-organ damage. We investigated whether body build was independently associated with higher cardiovascular risk and whether treatment with losartan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::337c5adcbec69084ade109e0e27ab272
https://doi.org/10.1161/01.cir.0000161799.91577.0a
https://doi.org/10.1161/01.cir.0000161799.91577.0a
Autor:
Hans Wedel, F Fyhrquist, R Devereux, U de Faire, M S Nieminen, K Kristianson, Thomas Hedner, Björn Dahlöf, S Kjeldsen, L H Lindholm, S Oparil, H Ibsen, Stevo Julius, P Omvik, O Lederballe-Pedersen
Publikováno v:
American Journal of Hypertension. 10:705-713
The treatment of hypertension mainly with diuretics and beta blockers reduces cardiovascular mortality and morbidity, largely due to a decreased incidence of stroke, whereas the beneficial effects of antihypertensive therapy on the occurrence of coro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c2df48d74188bbf295078bde6c81990
https://doi.org/10.1016/s0895-7061(97)00054-x
https://doi.org/10.1016/s0895-7061(97)00054-x
Publikováno v:
Heart. 65:249-255
Neuroendocrine activity was studied in 60 consecutive untreated patients with dyspnoea and a clinical suspicion of heart failure. On the basis of the so-called Boston clinical criteria the diagnosis of heart failure was regarded as unlikely in 26 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753c9237ff6eebe6be980cfc370ceb30
https://doi.org/10.1136/hrt.65.5.249
https://doi.org/10.1136/hrt.65.5.249
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vasilios Papademetriou, Stanley S. Franklin, Kristian Wachtell, Michael H. Olsen, Hans Ibsen, Björn Dahlöf, F Fyhrquist, Richard B. Devereux, Sverre E. Kjeldsen
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 46(3)
We hypothesized that losartan was superior to atenolol in reducing cardiovascular events in a lower-risk group (LRG) versus a higher-risk group (HRG) of patients in a Losartan Intervention For Endpoint reduction (LIFE) substudy, independently of bloo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0286aa481703c690bde59e722b670dd2
https://pubmed.ncbi.nlm.nih.gov/16116047
https://pubmed.ncbi.nlm.nih.gov/16116047
Publikováno v:
Scandinavian journal of rheumatology. 34(2)
(2005). Serum activity of endothelin‐converting enzyme correlates negatively with vital capacity in systemic sclerosis. Scandinavian Journal of Rheumatology: Vol. 34, No. 2, pp. 161-162.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8bf6d7bc5fef790ccfc72ac6b100fe7
https://pubmed.ncbi.nlm.nih.gov/16095018
https://pubmed.ncbi.nlm.nih.gov/16095018
Autor:
Björn Dahlöf, Richard B. Devereux, Krister Kristianson, Hans Wedel, Jonathan M. Edelman, Stevo Julius, Ulf de Faire, Hans Ibsen, Darcy A. Hille, Gareth Beevers, Lars H Lindholm, Sverre E. Kjeldsen, Paulette A. Lyle, Markku S. Nieminen, Per Omvik, Steven M. Snapinn, F Fyhrquist, Suzanne Oparil, Ole Lederballe-Pedersen
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 45(4)
In the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study, the primary composite end point of cardiovascular death, stroke, and myocardial infarction was reduced by losartan versus atenolol in patients with hypertension and lef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac776630958676dfbd0a9b564906ebfb
https://pubmed.ncbi.nlm.nih.gov/16027242
https://pubmed.ncbi.nlm.nih.gov/16027242
Autor:
Richard B. Devereux, Ying Wan, Markku S. Nieminen, Carl Erik Mogensen, Lars H Lindholm, Björn Dahlöf, Kristian Wachtell, Ulf de Faire, Knut Borch-Johnsen, Stevo Julius, Hans Ibsen, Michael H. Olsen, F Fyhrquist, Per Omvik, Ole Lederballe-Pedersen, Suzanne Oparil, Sverre E. Kjeldsen
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 45(2)
Few data are available to clarify whether changes in albuminuria over time translate to changes in cardiovascular risk. The aim of the present study was to examine whether changes in albuminuria during 4.8 years of antihypertensive treatment were rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c76feaf99d8427dd2052b89309ac04c
https://pubmed.ncbi.nlm.nih.gov/15642773
https://pubmed.ncbi.nlm.nih.gov/15642773